Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112635103 | 11263510 | 3 | F | 201003 | 20160630 | 20150713 | 20160706 | EXP | CA-ROCHE-1606398 | ROCHE | 15.00 | YR | F | Y | 0.00000 | 20160706 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 112635103 | 11263510 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Unknown | U | 125276 | ||||||||||
| 112635103 | 11263510 | 2 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | ||||||||||
| 112635103 | 11263510 | 3 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | U | 0 | 25 | MG | BIW | |||||||
| 112635103 | 11263510 | 4 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | U | 0 | ||||||||||
| 112635103 | 11263510 | 5 | SS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | U | 0 | ||||||||||
| 112635103 | 11263510 | 6 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Unknown | U | 0 | ||||||||||
| 112635103 | 11263510 | 7 | SS | ARTHROTEC | DICLOFENAC SODIUMMISOPROSTOL | 1 | Oral | U | 0 | 75 | MG | TABLET | |||||||
| 112635103 | 11263510 | 8 | C | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 0 | 40 | MG | /wk | ||||||||
| 112635103 | 11263510 | 9 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | 20 | MG | /wk | ||||||||
| 112635103 | 11263510 | 10 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | 25 | MG | /wk | ||||||||
| 112635103 | 11263510 | 11 | C | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 0 | 5 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 112635103 | 11263510 | 1 | Rheumatoid arthritis |
| 112635103 | 11263510 | 2 | Rheumatoid arthritis |
| 112635103 | 11263510 | 3 | Rheumatoid arthritis |
| 112635103 | 11263510 | 4 | Juvenile idiopathic arthritis |
| 112635103 | 11263510 | 5 | Rheumatoid arthritis |
| 112635103 | 11263510 | 6 | Rheumatoid arthritis |
| 112635103 | 11263510 | 7 | Product used for unknown indication |
| 112635103 | 11263510 | 11 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 112635103 | 11263510 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 112635103 | 11263510 | Drug ineffective | |
| 112635103 | 11263510 | Juvenile idiopathic arthritis | |
| 112635103 | 11263510 | Rheumatoid arthritis | |
| 112635103 | 11263510 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 112635103 | 11263510 | 3 | 20090903 | 20110726 | 0 | |
| 112635103 | 11263510 | 8 | 201106 | 201109 | 0 | |
| 112635103 | 11263510 | 9 | 2009 | 0 | ||
| 112635103 | 11263510 | 10 | 201503 | 0 | ||
| 112635103 | 11263510 | 11 | 20150717 | 0 |